200 related articles for article (PubMed ID: 32210430)
21. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma.
Thomas R; Borst L; Rotroff D; Motsinger-Reif A; Lindblad-Toh K; Modiano JF; Breen M
Chromosome Res; 2014 Sep; 22(3):305-19. PubMed ID: 24599718
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiles of beta-adrenergic receptors in canine vascular tumors: a preliminary study.
Clanxet J; Teles M; Hernández-Losa J; Rueda MR; Benitez-Fusté L; Pastor J
BMC Vet Res; 2022 May; 18(1):206. PubMed ID: 35637463
[TBL] [Abstract][Full Text] [Related]
23. Current understanding of comparative pathology and prospective research approaches for canine hemangiosarcoma.
Suzuki T; Henshaw MJ; Yanagi T; Aoshima K
Res Vet Sci; 2024 Feb; 167():105120. PubMed ID: 38150941
[TBL] [Abstract][Full Text] [Related]
24. Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
Prenen H; Smeets D; Mazzone M; Lambrechts D; Sagaert X; Sciot R; Debiec-Rychter M
Oncotarget; 2015 Nov; 6(34):36418-25. PubMed ID: 26474454
[TBL] [Abstract][Full Text] [Related]
25. Mutations in PIK3CA are infrequent in neuroblastoma.
Dam V; Morgan BT; Mazanek P; Hogarty MD
BMC Cancer; 2006 Jul; 6():177. PubMed ID: 16822308
[TBL] [Abstract][Full Text] [Related]
26. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
Painter CA; Jain E; Tomson BN; Dunphy M; Stoddard RE; Thomas BS; Damon AL; Shah S; Kim D; Gómez Tejeda Zañudo J; Hornick JL; Chen YL; Merriam P; Raut CP; Demetri GD; Van Tine BA; Lander ES; Golub TR; Wagle N
Nat Med; 2020 Feb; 26(2):181-187. PubMed ID: 32042194
[TBL] [Abstract][Full Text] [Related]
27. Molecular prevalence of Bartonella, Babesia, and hemotropic Mycoplasma species in dogs with hemangiosarcoma from across the United States.
Lashnits E; Neupane P; Bradley JM; Richardson T; Thomas R; Linder KE; Breen M; Maggi RG; Breitschwerdt EB
PLoS One; 2020; 15(1):e0227234. PubMed ID: 31923195
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
Adachi M; Hoshino Y; Izumi Y; Takagi S
J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
[TBL] [Abstract][Full Text] [Related]
29.
Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
[TBL] [Abstract][Full Text] [Related]
30. High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines.
Morita A; Aoshima K; Gulay KCM; Onishi S; Shibata Y; Yasui H; Kobayashi A; Kimura T
Res Vet Sci; 2019 Dec; 127():1-10. PubMed ID: 31648115
[TBL] [Abstract][Full Text] [Related]
31. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
[TBL] [Abstract][Full Text] [Related]
32. Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.
Rodriguez AM; Graef AJ; LeVine DN; Cohen IR; Modiano JF; Kim JH
J Vet Intern Med; 2015; 29(4):1088-97. PubMed ID: 26118793
[TBL] [Abstract][Full Text] [Related]
33. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
Therkildsen C; Bergmann TK; Henrichsen-Schnack T; Ladelund S; Nilbert M
Acta Oncol; 2014 Jul; 53(7):852-64. PubMed ID: 24666267
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
[TBL] [Abstract][Full Text] [Related]
35. Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines.
Adachi M; Hoshino Y; Izumi Y; Sakai H; Takagi S
Can J Vet Res; 2016 Jul; 80(3):209-16. PubMed ID: 27408334
[TBL] [Abstract][Full Text] [Related]
36. Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
Cossu-Rocca P; Orrù S; Muroni MR; Sanges F; Sotgiu G; Ena S; Pira G; Murgia L; Manca A; Uras MG; Sarobba MG; Urru S; De Miglio MR
PLoS One; 2015; 10(11):e0141763. PubMed ID: 26540293
[TBL] [Abstract][Full Text] [Related]
37. Primary appendicular hemangiosarcoma and telangiectatic osteosarcoma in 70 dogs: A Veterinary Society of Surgical Oncology retrospective study.
Giuffrida MA; Kamstock DA; Selmic LE; Pass W; Szivek A; Mison MB; Boston SE; Fox LE; Robat C; Grimes JA; Maritato KC; Bacon NJ
Vet Surg; 2018 Aug; 47(6):774-783. PubMed ID: 30051473
[TBL] [Abstract][Full Text] [Related]
38. Hemangiosarcoma in dogs and cats.
Smith AN
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):533-52, vi. PubMed ID: 12852235
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.
Lucroy MD; Clauson RM; Suckow MA; El-Tayyeb F; Kalinauskas A
BMC Vet Res; 2020 Nov; 16(1):447. PubMed ID: 33208160
[TBL] [Abstract][Full Text] [Related]
40. Role of monocyte recruitment in hemangiosarcoma metastasis in dogs.
Regan DP; Escaffi A; Coy J; Kurihara J; Dow SW
Vet Comp Oncol; 2017 Dec; 15(4):1309-1322. PubMed ID: 27779362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
